logo
Plus   Neg
Share
Email

Novartis Pledges To Release Information On Manipulated Data In Future

Novartis (NVS) has committed to notifying the Food and Drug Administration within five business days of learning of any "credible allegation" in which manipulated data may affect a pending marketing application before the agency or regulators in other countries.

"We are making a voluntary commitment to notify the FDA within five business days of receipt by our quality (control) organization of any credible allegation related to data integrity impacting any pending application in the Novartis Group," Chief Executive Officer Vas Narasimhan said at an investor event. The company will take a similar approach in other jurisdictions.

The commitment was made to the FDA last month as part of a formal response to an August 2 inspection report of a facility.

The report noted that Novartis apparently first became aware of manipulated data concerning a gene therapy last March, but waited to inform the agency until after the treatment was approved in May.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network. Mitsubishi Motors North America inc. recalled 141,200 cars and sports utility vehicles (SUVs) due to potential corrosion of the front cross member because of salt water exposure such as from road salt use in cold-weather, according to the National Highway Traffic Safety Administration. The recall is expected to begin on July 14, 2020.
Follow RTT